Skip to Content

Franklin Genomic Advancements ETF

HELX
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Feb 25 2020
Expense Ratio
0.50%
Type
Global Equities
Fund Owner
Franklin Templeton
Volume (1m avg. daily)
$59,521
AUM
$10,307,500
Associated Index
None
Inverse/Leveraged
No
Passive/Active
Active
Fractionable on Composer
No
Prospectus

Top 10 Holdings

TMO
Thermo Fisher Scientific Inc.
6.59%
DHR
Danaher Corp.
5.81%
RGEN
Repligen Corp.
5.52%
SRT3
SARTORIUS AG-VORZUG
4.32%
MEDP
Medpace Holdings Inc
3.96%
REGN
Regeneron Pharmaceuticals, Inc.
3.83%
MRNA
Moderna Inc
3.80%
VRTX
Vertex Pharmaceuticals, Inc.
3.55%
207940
Samsung Biologics Co Ltd
3.45%
BRKR
Bruker Corp
3.03%
Invest with HELX

What is HELX?

The Fund invests at least 80% of its net assets in equity securities of companies that are relevant to the Fund s investment theme of genomic advancements. The Fund invests predominantly in common stock. The Fund s investment theme of genomic advancements are those that the investment manager believes are substantially focused on and/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business, such as by offering new products or services that rely on genetic engineering, gene therapy, genome analysis, DNA sequencing, synthesis or instrumentation. These companies may include those that research, develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and diagnostics, pharmaceuticals and agricultural applications of genomics, and related equipment, techniques and processes.

ETFs related toHELX

ETFs correlated to HELX include GJAN, VBK, GFEB

HELX
Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF
GJAN
First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Moderate Buffer ETF - January
VBK
Vanguard Group, Inc. - Vanguard Small Cap Growth ETF
GFEB
First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Moderate Buffer ETF - February
NUMG
Nuveen Fund Advisors LLC - Nuveen ESG Mid-Cap Growth ETF
VOT
Vanguard Group, Inc. - Vanguard Mid-Cap Growth ETF
FXH
First Trust Exchange-Traded Fund III - First Trust Health Care AlphaDEX Fund
CVLC
Morgan Stanley ETF Trust - Calvert US Large-Cap Core Responsible Index ETF
RYH
Invesco Capital Management LLC - Invesco S&P 500 Equal Weight Health Care ETF
IMCG
BlackRock Institutional Trust Company N.A. - iShares Morningstar Mid-Cap Growth ETF
IWP
BlackRock Institutional Trust Company N.A. - iShares Russell Mid-Cap Growth ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

Automated Strategies
Related toHELX

#GLOMO

On Top of the World: Global Momentum

Category

Momentum, Lever Up, Go Global

Risk Rating

Moderate

Create your own algorithmic trading strategy with HELX using Composer

FAQ

HELX is a Global Equities ETF. The Fund invests at least 80% of its net assets in equity securities of companies that are relevant to the Fund s investment theme of genomic advancements. The Fund invests predominantly in common stock. The Fund s investment theme of genomic advancements are those that the investment manager believes are substantially focused on and/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business, such as by offering new products or services that rely on genetic engineering, gene therapy, genome analysis, DNA sequencing, synthesis or instrumentation. These companies may include those that research, develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and diagnostics, pharmaceuticals and agricultural applications of genomics, and related equipment, techniques and processes.

Yes, HELX is actively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

No, HELX is not passively managed. It is actively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on HELX is -0.0271%. This is the percent change in the value of HELX over the most recent 1-month period. The 3-month return on HELX is -0.0313%. This is the percent change in the value of HELX over the most recent 3-month period.

The standard deviation of HELX for the past year is 0.2916%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to HELX include IXN, IXC, and GDXJ.

ETFs correlated to HELX include GJAN, VBK, and GFEB.

ETFs that are inversely correlated to HELX include RWM, SRTY, and TZA.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.